Arbovirus Testing Market Report: Trends, Forecast and Competitive Analysis to 2030

Arbovirus Testing Market Report: Trends, Forecast and Competitive Analysis to 2030

Arbovirus Testing Trends and Forecast

The future of the global arbovirus testing market looks promising with opportunities in the hospital, diagnostic center, and public health laboratory markets. The global arbovirus testing market is expected to grow with a CAGR of 5.8% from 2024 to 2030. The major drivers for this market are growing government initiatives to raise public knowledge of arbovirus-caused neglected tropical diseases (NTDs), like dengue and chikungunya, increasing number of people suffering from viral diseases spread by arthropods, as well as, rising knowledge of the diseases in the general population and among patients and doctors about the advantages of early arbovirus testing.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Arbovirus Testing by Segment

The study includes a forecast for the global arbovirus testing by test type, end use, and region.

Arbovirus Testing Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

• RT-PCR Tests
• ELISA Tests

Arbovirus Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Diagnostic Centers
• Public Health Laboratories

Arbovirus Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Arbovirus Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies arbovirus testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the arbovirus testing companies profiled in this report include-

• Abbott
• Thermo Fisher Scientific
• NovaTec Immundiagnostica
• Agilent Technologies
• Quidel Corporation
• OraSure Technologies
• Hologic

Arbovirus Testing Market Insights

Lucintel forecasts that ELISA test will remain the larger segment over the forecast period due to heightened emphasis on the research and development of new ELISA tests and their advantages compared to RT-PCR tests.

Within this market, public health laboratory will remain the largest segment due to strong need for arbovirus testing at public health facilities to identify chikungunya and dengue, as well as, increase in government programs offering various services, like financing for diagnostic tests.

North America will remain the largest region over the forecast period due to increasing prevalence of non-communicable diseases (NTDs) like dengue and chikungunya, rising healthcare expenditures, swift technology advancements, and an increase in patients' awareness of the value of arbovirus testing in identifying these NTDs.

Features of the Global Arbovirus Testing Market

Market Size Estimates: Arbovirus testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Arbovirus testing market size by test type, end use, and region in terms of value ($B).

Regional Analysis: Arbovirus testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different test type, end use, and regions for the arbovirus testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the arbovirus testing market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the growth forecast for arbovirus testing market?

Answer: The global arbovirus testing market is expected to grow with a CAGR of 5.8% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the arbovirus testing market?

Answer: The major drivers for this market are growing government initiatives to raise public knowledge of arbovirus-caused neglected tropical diseases (NTDs), like dengue and chikungunya, increasing number of people suffering from viral diseases spread by arthropods, as well as, rising knowledge of the diseases in the general population and among patients and doctors about the advantages of early arbovirus testing.

Q3. What are the major segments for arbovirus testing market?

Answer: The future of the global arbovirus testing market looks promising with opportunities in the hospital, diagnostic center, and public health laboratory markets.

Q4. Who are the key arbovirus testing market companies?

Answer: Some of the key arbovirus testing companies are as follows:

• Abbott
• Thermo Fisher Scientific
• NovaTec Immundiagnostica
• Agilent Technologies
• Quidel Corporation
• OraSure Technologies
• Hologic

Q5. Which arbovirus testing market segment will be the largest in future?

Answer: Lucintel forecasts that ELISA test will remain the larger segment over the forecast period due to heightened emphasis on the research and development of new ELISA tests and their advantages compared to RT-PCR tests.

Q6. In arbovirus testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing prevalence of non-communicable diseases (NTDs) like dengue and chikungunya, rising healthcare expenditures, swift technology advancements, and an increase in patients' awareness of the value of arbovirus testing in identifying these NTDs.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the arbovirus testing market by test type (RT-PCR tests and ELISA tests), end use (hospitals, diagnostic centers, and public health laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Please note: It will take 2-3 business days to deliver the report upon receipt the order.